Published in J Clin Oncol on September 01, 2004
Cognitively-Based Compassion Training for Breast Cancer Survivors (CBCT-BC) | NCT03305952
The influence of bio-behavioural factors on tumour biology: pathways and mechanisms. Nat Rev Cancer (2006) 4.27
Psychologic intervention improves survival for breast cancer patients: a randomized clinical trial. Cancer (2008) 3.68
Stress hormone-mediated invasion of ovarian cancer cells. Clin Cancer Res (2006) 3.58
Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. J Clin Oncol (2008) 3.30
Decrease in depression symptoms is associated with longer survival in patients with metastatic breast cancer: a secondary analysis. J Clin Oncol (2010) 2.33
Positive psychology in cancer care: bad science, exaggerated claims, and unproven medicine. Ann Behav Med (2010) 2.19
Effect of mindfulness based stress reduction on immune function, quality of life and coping in women newly diagnosed with early stage breast cancer. Brain Behav Immun (2008) 2.11
Biobehavioral, immune, and health benefits following recurrence for psychological intervention participants. Clin Cancer Res (2010) 1.76
Marital quality and survivorship: slowed recovery for breast cancer patients in distressed relationships. Cancer (2009) 1.60
Distress reduction from a psychological intervention contributes to improved health for cancer patients. Brain Behav Immun (2007) 1.59
Stress effects on FosB- and interleukin-8 (IL8)-driven ovarian cancer growth and metastasis. J Biol Chem (2010) 1.58
Association of the physiological stress response with depressive symptoms in patients with breast cancer. Psychosom Med (2014) 1.52
Host factors and cancer progression: biobehavioral signaling pathways and interventions. J Clin Oncol (2010) 1.47
Cognitive behavioral stress management effects on psychosocial and physiological adaptation in women undergoing treatment for breast cancer. Brain Behav Immun (2008) 1.42
Psychological responses to cancer recurrence. Cancer (2005) 1.34
Pre-intervention distress moderates the efficacy of psychosocial treatment for cancer patients: a meta-analysis. J Behav Med (2009) 1.32
Caregiver-assisted coping skills training for lung cancer: results of a randomized clinical trial. J Pain Symptom Manage (2010) 1.27
PTSD diagnoses, subsyndromal symptoms, and comorbidities contribute to impairments for breast cancer survivors. J Trauma Stress (2008) 1.25
A psychological intervention reduces inflammatory markers by alleviating depressive symptoms: secondary analysis of a randomized controlled trial. Psychosom Med (2009) 1.22
Individual trajectories in stress covary with immunity during recovery from cancer diagnosis and treatments. Brain Behav Immun (2006) 1.18
Psychological intervention and health outcomes among women treated for breast cancer: a review of stress pathways and biological mediators. Brain Behav Immun (2008) 1.17
RCT of a psychological intervention for patients with cancer: I. mechanisms of change. J Consult Clin Psychol (2007) 1.15
Depressed and anxious mood and T-cell cytokine expressing populations in ovarian cancer patients. Brain Behav Immun (2008) 1.13
Psychosocial intervention effects on adaptation, disease course and biobehavioral processes in cancer. Brain Behav Immun (2012) 1.10
Surviving recurrence: psychological and quality-of-life recovery. Cancer (2008) 1.08
Immune, endocrine, and behavioral precursors to breast cancer recurrence: a case-control analysis. Cancer Immunol Immunother (2008) 1.08
Biobehavioral influences on cancer progression. Immunol Allergy Clin North Am (2011) 1.04
Psychological stress is associated with altered levels of myeloid-derived suppressor cells in breast cancer patients. Cell Immunol (2011) 1.03
Challenges and Needs of Chinese and Korean American Breast Cancer Survivors: In-Depth Interviews. N Am J Med Sci (Boston) (2013) 1.00
Strategies used in coping with a cancer diagnosis predict meaning in life for survivors. Health Psychol (2006) 0.98
Determinants of physical activity among women treated for breast cancer in a 5-year longitudinal follow-up investigation. Psychooncology (2009) 0.96
Optimism, social support, and adjustment in African American women with breast cancer. J Behav Med (2008) 0.96
Religious Practice and Spirituality in the Psychological Adjustment of Survivors of Breast Cancer. Couns Values (2009) 0.95
Biobehavioral approaches to cancer progression and survival: Mechanisms and interventions. Am Psychol (2015) 0.94
Cancer patients with major depressive disorder: testing a biobehavioral/cognitive behavior intervention. J Consult Clin Psychol (2011) 0.94
Delayed emotional recovery after taxane-based chemotherapy. Cancer (2008) 0.93
Impaired natural killer cell lysis in breast cancer patients with high levels of psychological stress is associated with altered expression of killer immunoglobin-like receptors. J Surg Res (2007) 0.93
Psychosocial adaptation and cellular immunity in breast cancer patients in the weeks after surgery: An exploratory study. J Psychosom Res (2009) 0.93
Physical and mental health status and health behaviors of survivors of multiple cancers: a national, population-based study. Ann Behav Med (2011) 0.92
Relationships among optimism, well-being, self-transcendence, coping, and social support in women during treatment for breast cancer. Psychooncology (2009) 0.92
Body change stress for women with breast cancer: the Breast-Impact of Treatment Scale. Ann Behav Med (2006) 0.89
Establishing treatment fidelity in a web-based behavioral intervention study. Nurs Res (2011) 0.89
Sexual well-being among partnered women with breast cancer recurrence. J Clin Oncol (2007) 0.89
Interleukin-29 binds to melanoma cells inducing Jak-STAT signal transduction and apoptosis. Mol Cancer Ther (2010) 0.88
Adherence to PEG/ribavirin treatment for chronic hepatitis C: prevalence, patterns, and predictors of missed doses and nonpersistence. J Viral Hepat (2013) 0.88
TNF-alpha levels in cancer patients relate to social variables. Brain Behav Immun (2005) 0.87
Chronic hepatitis C and antiviral treatment regimens: where can psychology contribute? J Consult Clin Psychol (2012) 0.87
Measuring meaning in life following cancer. Qual Life Res (2006) 0.86
Childhood adversity increases vulnerability for behavioral symptoms and immune dysregulation in women with breast cancer. Brain Behav Immun (2012) 0.86
An online stress management workbook for breast cancer. J Behav Med (2012) 0.86
A systematic review of therapeutic alliance, group cohesion, empathy, and goal consensus/collaboration in psychotherapeutic interventions in cancer: Uncommon factors? Clin Psychol Rev (2009) 0.86
Stress generation over the course of breast cancer survivorship. J Behav Med (2010) 0.85
Test of mindfulness and hope components in a psychological intervention for women with cancer recurrence. J Consult Clin Psychol (2014) 0.85
Investigating the perceived feasibility of integrative medicine in a conventional oncology setting: yoga therapy as a treatment for breast cancer survivors. Integr Cancer Ther (2012) 0.84
Alterations in the Th1/Th2 balance in breast cancer patients using reflexology and scalp massage. Exp Ther Med (2010) 0.84
β-blockers: a novel class of antitumor agents. Onco Targets Ther (2012) 0.84
Psychosocial telephone counseling for survivors of cervical cancer: results of a randomized biobehavioral trial. J Clin Oncol (2015) 0.84
Effect of chronic restraint stress on human colorectal carcinoma growth in mice. PLoS One (2013) 0.83
In sickness and in health: maintaining intimacy after breast cancer recurrence. Cancer J (2009) 0.82
Brief cognitive-behavioral and relaxation training interventions for breast cancer: A randomized controlled trial. J Consult Clin Psychol (2015) 0.82
Impact of breast cancer recurrence and cancer-specific stress on spouse health and immune function. Brain Behav Immun (2011) 0.81
Epigenetic patterns associated with the immune dysregulation that accompanies psychosocial distress. Brain Behav Immun (2010) 0.80
Immune response, depression and fatigue in relation to support intervention in mammary cancer patients. Support Care Cancer (2007) 0.80
Psychoneuroimmunology examined: The role of subjective stress. Cellscience (2006) 0.80
Dissemination of an evidence-based treatment for cancer patients: training is the necessary first step. Transl Behav Med (2015) 0.79
Effects of cognitive behavioral counseling on body Image following mastectomy. J Res Med Sci (2011) 0.79
Psychosocial moderators of presurgical stress management for men undergoing radical prostatectomy. Health Psychol (2012) 0.78
Nerve fibers in breast cancer tissues indicate aggressive tumor progression. Medicine (Baltimore) (2014) 0.78
Effects of psycho-behavioral interventions on immune functioning in cancer patients: a systematic review. J Cancer Res Clin Oncol (2013) 0.78
A pilot study of an exercise & cognitive behavioral therapy intervention for epithelial ovarian cancer patients. J Ovarian Res (2013) 0.78
A unique interactive cognitive behavioral training program for front-line cancer care professionals. J Cancer Educ (2012) 0.78
E-counseling in psychosocial cancer care: a survey of practice, attitudes, and training among providers. Telemed J E Health (2012) 0.78
Psychological aspect of cancer: From stressor to cancer progression. Exp Ther Med (2010) 0.77
Targeted drugs and Psycho-oncological intervention for breast cancer patients. J Negat Results Biomed (2016) 0.77
Peer support of complex health behaviors in prevention and disease management with special reference to diabetes: systematic reviews. Clin Diabetes Endocrinol (2017) 0.77
Evidence-based psychosocial treatment in the community: considerations for dissemination and implementation. Psychooncology (2015) 0.76
Emotions and social relationships for breast and gynecologic patients: a qualitative study of coping with recurrence. Psychooncology (2013) 0.76
A Comprehensive Lifestyle Randomized Clinical Trial: Design and Initial Patient Experience. Integr Cancer Ther (2016) 0.76
Fine-tuning the truth. World J Surg (2011) 0.75
Disease burden and pain in obese cancer patients with chemotherapy-induced peripheral neuropathy. Support Care Cancer (2017) 0.75
Effect of chemotherapy counseling by pharmacists on quality of life and psychological outcomes of oncology patients in Malaysia: a randomized control trial. Health Qual Life Outcomes (2017) 0.75
Emotions and Emotion Regulation in Breast Cancer Survivorship. Healthcare (Basel) (2016) 0.75
The effectiveness of mindfulness-based stress reduction (MBSR) for survivors of breast cancer: study protocol for a randomized controlled trial. Trials (2016) 0.75
Stress management, leukocyte transcriptional changes and breast cancer recurrence in a randomized trial: An exploratory analysis. Psychoneuroendocrinology (2016) 0.75
Trajectories of Stress, Depressive Symptoms, and Immunity in Cancer Survivors: Diagnosis to 5 Years. Clin Cancer Res (2016) 0.75
Contemplative self healing in women breast cancer survivors: a pilot study in underserved minority women shows improvement in quality of life and reduced stress. BMC Complement Altern Med (2014) 0.75
Illustrating the Multi-Faceted Dimensions of Group Therapy and Support for Cancer Patients. Healthcare (Basel) (2016) 0.75
Distance art groups for women with breast cancer: guidelines and recommendations. Support Care Cancer (2006) 0.75
Implementation of an evidence-based biobehavioral treatment for cancer patients. Transl Behav Med (2017) 0.75
From will to live to will to die: oncologists, nurses, and social workers identification of suicidality in cancer patients. Support Care Cancer (2017) 0.75
What is the state of the evidence on the mind-cancer survival question, and where do we go from here? A point of view. Support Care Cancer (2007) 0.75
Impact of Event Scale: a measure of subjective stress. Psychosom Med (1979) 21.82
Social networks, host resistance, and mortality: a nine-year follow-up study of Alameda County residents. Am J Epidemiol (1979) 20.47
Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet (1989) 10.39
Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proc Natl Acad Sci U S A (1998) 6.82
Assessment of habitual physical activity by a seven-day recall in a community survey and controlled experiments. Am J Epidemiol (1985) 6.10
The effect of group psychosocial support on survival in metastatic breast cancer. N Engl J Med (2001) 5.95
Allocation of patients to treatment groups in a controlled clinical study. Br J Cancer (1978) 5.25
The Karnofsky Performance Status Scale. An examination of its reliability and validity in a research setting. Cancer (1984) 5.24
Evaluation of patients with advanced cancer using the Karnofsky performance status. Cancer (1980) 4.31
Cognitive-behavioral stress management intervention decreases the prevalence of depression and enhances benefit finding among women under treatment for early-stage breast cancer. Health Psychol (2001) 4.23
Measures of perceived social support from friends and from family: three validation studies. Am J Community Psychol (1983) 4.22
Adherence to therapy with oral antineoplastic agents. J Natl Cancer Inst (2002) 4.16
Stress and immune responses after surgical treatment for regional breast cancer. J Natl Cancer Inst (1998) 3.77
Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. Semin Hematol (1997) 3.27
Group support for patients with metastatic cancer. A randomized outcome study. Arch Gen Psychiatry (1981) 3.17
Perceived support, received support, and adjustment to stressful life events. J Health Soc Behav (1986) 2.74
Emotional support and survival after myocardial infarction. A prospective, population-based study of the elderly. Ann Intern Med (1992) 2.62
A biobehavioral model of cancer stress and disease course. Am Psychol (1994) 2.57
Social support and adjustment to cancer: reconciling descriptive, correlational, and intervention research. Health Psychol (1996) 2.46
Group support interventions for women with breast cancer: who benefits from what? Health Psychol (2000) 2.38
Malignant melanoma. Effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later. Arch Gen Psychiatry (1993) 2.38
The effect of psychological interventions on anxiety and depression in cancer patients: results of two meta-analyses. Br J Cancer (1999) 2.34
Clinical interventions in tobacco control. A National Cancer Institute training program for physicians. JAMA (1991) 2.27
Structured exercise improves physical functioning in women with stages I and II breast cancer: results of a randomized controlled trial. J Clin Oncol (2001) 2.16
Anxiety-related reactions associated with magnetic resonance imaging examinations. JAMA (1993) 2.15
Psychoneuroimmunology: psychological influences on immune function and health. J Consult Clin Psychol (2002) 2.10
Psychological sequelae of cancer diagnosis: a meta-analytical review of 58 studies after 1980. Psychosom Med (1997) 2.05
Predictors of long-term smoking cessation in head and neck cancer patients. Cancer Epidemiol Biomarkers Prev (1993) 1.94
The existential plight in cancer: significance of the first 100 days. Int J Psychiatry Med (1976) 1.74
Analysis of dose intensity for adjuvant chemotherapy trials in stage II breast cancer. J Clin Oncol (1986) 1.73
A structured psychiatric intervention for cancer patients. II. Changes over time in immunological measures. Arch Gen Psychiatry (1990) 1.71
Psychological interventions for cancer patients to enhance the quality of life. J Consult Clin Psychol (1992) 1.71
Anxiety in cancer patients. Br J Cancer (2000) 1.67
A structured psychiatric intervention for cancer patients. I. Changes over time in methods of coping and affective disturbance. Arch Gen Psychiatry (1990) 1.66
Adherence to a dietary fat intake reduction program in postmenopausal women receiving therapy for early breast cancer. The Women's Intervention Nutrition Study. J Clin Oncol (1993) 1.64
Fatigue and the cancer experience: the state of the knowledge. Oncol Nurs Forum (1994) 1.62
Psychosocial benefits of a cancer support group. Cancer (1986) 1.62
Group therapy and hypnosis reduce metastatic breast carcinoma pain. Psychosom Med (1983) 1.60
Lack of social support and incidence of coronary heart disease in middle-aged Swedish men. Psychosom Med (1993) 1.57
Effects of counseling for late stage cancer patients. Cancer (1982) 1.55
Effects of aerobic interval training on cancer patients' functional capacity. Nurs Res (1990) 1.52
Biobehavioral outcomes following psychological interventions for cancer patients. J Consult Clin Psychol (2002) 1.52
The importance of dose intensity in the outcome of chemotherapy. Important Adv Oncol (1988) 1.47
Longitudinal predictors of continued tobacco use among patients diagnosed with cancer. Ann Behav Med (2003) 1.45
A randomized controlled trial of the effects of group psychological therapy on survival in women with metastatic breast cancer. Psychooncology (1999) 1.43
Social networks and health-related quality of life in breast cancer survivors: a prospective study. J Psychosom Res (2002) 1.37
The influence of symptoms of disease and side effects of treatment on compliance with cancer therapy. J Clin Oncol (1988) 1.34
Posttraumatic stress disorder symptoms after bone marrow transplantation for breast cancer. Psychosom Med (1998) 1.26
A group cognitive behaviour therapy programme with metastatic breast cancer patients. Psychooncology (1999) 1.25
Psychological response to long-term group therapy: a randomized trial with metastatic breast cancer patients. Psychooncology (1999) 1.22
The effect of counselling on physical disability and social recovery after mastectomy. Clin Oncol (1983) 1.18
Psychosocial rehabilitation of gynecologic oncology patients. Arch Phys Med Rehabil (1980) 1.18
Quality of life in a randomized trial of group psychosocial support in metastatic breast cancer: overall effects of the intervention and an exploration of missing data. J Clin Oncol (2003) 1.17
Behavioral intervention for cancer treatment side effects. J Natl Cancer Inst (2001) 1.16
Impact of psychotherapeutic support on gastrointestinal cancer patients undergoing surgery: survival results of a trial. Hepatogastroenterology (1999) 1.07
Rapid assessment of dietary intake of fat, fiber, and saturated fat: validity of an instrument suitable for community intervention research and nutritional surveillance. Am J Health Promot (1990) 1.05
A nurse-delivered smoking cessation intervention among hospitalized postoperative patients--influence of a smoking-related diagnosis: a pilot study. Heart Lung (1994) 1.03
Feasibility of a randomized trial of a high-vegetable diet to prevent breast cancer recurrence. Nutr Cancer (1997) 1.02
Effectiveness of a short-term group psychotherapy program on endocrine and immune function in breast cancer patients: an exploratory study. J Psychosom Res (1997) 1.01
Immunological responses of breast cancer patients to behavioral interventions. Biofeedback Self Regul (1993) 1.00
Effects of group CBT on the survival time of patients with metastatic breast cancer. Psychooncology (2000) 1.00
Psychological effects of stomas--I. Psychosocial morbidity one year after surgery. J Psychosom Res (1987) 0.97
Behavioral medicine: 2002 and beyond. J Consult Clin Psychol (2002) 0.97
Path model of multidimensional compliance with cancer therapy. Health Psychol (1987) 0.93
Nausea and emesis: evidence for a biobehavioral perspective. Support Care Cancer (2001) 0.92
A presurgical psychosocial intervention for breast cancer patients. psychological distress and the immune response. J Psychosom Res (2000) 0.91
Anxiety and cancer treatment: response to stressful radiotherapy. Health Psychol (1984) 0.91
Explaining retrospective reports of symptoms in patients undergoing chemotherapy: anxiety, initial symptom experience, and posttreatment symptoms. Health Psychol (2001) 0.90
Former cancer patients as counselors of newly diagnosed cancer patients. J Natl Cancer Inst (1986) 0.89
Coping, life attitudes, and immune responses to imagery and group support after breast cancer treatment. Altern Ther Health Med (1997) 0.88
Dietary intervention in breast cancer patients: effects on food choice. Eur J Clin Nutr (1992) 0.87
Psychosocial status at initiation of cancer treatment and survival. J Psychosom Res (1990) 0.86
Feasibility of using volunteer research staff to deliver and evaluate a low-fat dietary intervention: the American Cancer Society Breast Cancer Dietary Intervention Project. Cancer Epidemiol Biomarkers Prev (1997) 0.85
Social relationships, recovery from illness, and survival: a literature review. Ann Behav Med (1995) 0.81
Effects of a structured psychiatric intervention on immune function of cancer patients. Tokai J Exp Clin Med (2000) 0.78
Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proc Natl Acad Sci U S A (2003) 5.26
Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines. Chest (2007) 5.01
MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1. J Biol Chem (2008) 4.56
American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. J Clin Oncol (2007) 4.45
Emotions, morbidity, and mortality: new perspectives from psychoneuroimmunology. Annu Rev Psychol (2002) 4.01
Psychologic intervention improves survival for breast cancer patients: a randomized clinical trial. Cancer (2008) 3.68
Accelerated telomere erosion is associated with a declining immune function of caregivers of Alzheimer's disease patients. J Immunol (2007) 3.20
Breast cancer. Clinical practice guidelines in oncology. J Natl Compr Canc Netw (2009) 3.17
Hostile marital interactions, proinflammatory cytokine production, and wound healing. Arch Gen Psychiatry (2005) 2.94
BEAM: a randomized phase II study evaluating the activity of bevacizumab in combination with carboplatin plus paclitaxel in patients with previously untreated advanced melanoma. J Clin Oncol (2011) 2.87
NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis. J Natl Compr Canc Netw (2009) 2.78
Mapping geographic zones of cancer risk with epigenetic biomarkers in normal breast tissue. Clin Cancer Res (2006) 2.70
Depression and immune function: central pathways to morbidity and mortality. J Psychosom Res (2002) 2.68
Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial. Lancet Oncol (2013) 2.59
Benefit from exemestane as extended adjuvant therapy after 5 years of adjuvant tamoxifen: intention-to-treat analysis of the National Surgical Adjuvant Breast And Bowel Project B-33 trial. J Clin Oncol (2008) 2.55
How stress influences the immune response. Trends Immunol (2003) 2.45
Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells. Cancer Res (2006) 2.32
Defining the critical hurdles in cancer immunotherapy. J Transl Med (2011) 2.32
Psychoneuroimmunology: psychological influences on immune function and health. J Consult Clin Psychol (2002) 2.10
Concurrent cisplatin, etoposide, and chest radiotherapy in pathologic stage IIIB non-small-cell lung cancer: a Southwest Oncology Group phase II study, SWOG 9019. J Clin Oncol (2002) 2.07
Childhood adversity heightens the impact of later-life caregiving stress on telomere length and inflammation. Psychosom Med (2010) 2.06
Thyroid carcinoma. J Natl Compr Canc Netw (2010) 2.02
Chronic herpesvirus reactivation occurs in aging. Exp Gerontol (2007) 1.99
NCCN Task Force Report: Bone Health in Cancer Care. J Natl Compr Canc Netw (2009) 1.97
Breast cancer, version 3.2013: featured updates to the NCCN guidelines. J Natl Compr Canc Netw (2013) 1.79
Psychoneuroimmunology and psychosomatic medicine: back to the future. Psychosom Med (2002) 1.77
Sex, depression, and risk of hospitalization and mortality in chronic obstructive pulmonary disease. Arch Intern Med (2007) 1.77
Omega-3 fatty acids, oxidative stress, and leukocyte telomere length: A randomized controlled trial. Brain Behav Immun (2012) 1.76
Biobehavioral, immune, and health benefits following recurrence for psychological intervention participants. Clin Cancer Res (2010) 1.76
Stress-induced immune dysregulation: implications for wound healing, infectious disease and cancer. J Neuroimmune Pharmacol (2006) 1.74
IL-12 enhances the natural killer cell cytokine response to Ab-coated tumor cells. J Clin Invest (2002) 1.74
p27(Kip1) and cyclin E expression and breast cancer survival after treatment with adjuvant chemotherapy. J Natl Cancer Inst (2006) 1.74
Differential expression of SHIP1 in CD56bright and CD56dim NK cells provides a molecular basis for distinct functional responses to monokine costimulation. Blood (2004) 1.73
Giant breast tumors: surgical management of phyllodes tumors, potential for reconstructive surgery and a review of literature. World J Surg Oncol (2008) 1.73
Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: implications for stress-related enhancement of tumor progression. Brain Behav Immun (2008) 1.71
Stress hormones and immune function. Cell Immunol (2008) 1.66
The activation of natural killer cell effector functions by cetuximab-coated, epidermal growth factor receptor positive tumor cells is enhanced by cytokines. Clin Cancer Res (2007) 1.66
Long-term efficacy of lymph node reoperation for persistent papillary thyroid cancer. J Clin Endocrinol Metab (2010) 1.65
Olfactory influences on mood and autonomic, endocrine, and immune function. Psychoneuroendocrinology (2008) 1.64
Breast cancer version 3.2014. J Natl Compr Canc Netw (2014) 1.63
Myeloid-derived suppressor cell inhibition of the IFN response in tumor-bearing mice. Cancer Res (2011) 1.61
Distress reduction from a psychological intervention contributes to improved health for cancer patients. Brain Behav Immun (2007) 1.59
Breast Cancer Version 2.2015. J Natl Compr Canc Netw (2015) 1.59
Interleukin-21 enhances NK cell activation in response to antibody-coated targets. J Immunol (2006) 1.58
Cyclooxygenase inhibitors suppress aromatase expression and activity in breast cancer cells. J Clin Endocrinol Metab (2005) 1.56
A phase I study of interleukin 12 with trastuzumab in patients with human epidermal growth factor receptor-2-overexpressing malignancies: analysis of sustained interferon gamma production in a subset of patients. Clin Cancer Res (2004) 1.55
β-Blockers and survival among Danish patients with malignant melanoma: a population-based cohort study. Cancer Epidemiol Biomarkers Prev (2011) 1.55
Depressive symptoms, omega-6:omega-3 fatty acids, and inflammation in older adults. Psychosom Med (2007) 1.54
A phase I trial of paclitaxel and trastuzumab in combination with interleukin-12 in patients with HER2/neu-expressing malignancies. Mol Cancer Ther (2009) 1.54
Anaplastic thyroid cancer. Endocrinol Metab Clin North Am (2008) 1.54
When fit indices and residuals are incompatible. Psychol Methods (2002) 1.51
β-Adrenergic receptor mediated increases in activation and function of natural killer cells following repeated social disruption. Brain Behav Immun (2012) 1.50
A randomized phase 2 trial of bevacizumab with or without daily low-dose interferon alfa-2b in metastatic malignant melanoma. Ann Surg Oncol (2007) 1.49
Stress, inflammation, and yoga practice. Psychosom Med (2010) 1.47
Distinct myeloid suppressor cell subsets correlate with plasma IL-6 and IL-10 and reduced interferon-alpha signaling in CD4⁺ T cells from patients with GI malignancy. Cancer Immunol Immunother (2011) 1.47
Contralateral prophylactic mastectomy for unilateral breast cancer: an increasing trend at a single institution. Ann Surg Oncol (2009) 1.46
Phase II trial of neoadjuvant chemotherapy with docetaxel followed by epirubicin in stage II/III breast cancer. Breast Cancer Res Treat (2005) 1.45
Melanoma, version 2.2013: featured updates to the NCCN guidelines. J Natl Compr Canc Netw (2013) 1.44
Factor V Leiden mutation and thromboembolism risk in women receiving adjuvant tamoxifen for breast cancer. J Natl Cancer Inst (2010) 1.44
Integrated microRNA and mRNA signatures associated with survival in triple negative breast cancer. PLoS One (2013) 1.43
Invasive breast cancer. J Natl Compr Canc Netw (2011) 1.43
Multiparametric flow cytometric analysis of inter-patient variation in STAT1 phosphorylation following interferon Alfa immunotherapy. J Natl Cancer Inst (2004) 1.42
Religious and spiritual coping and quality of life among patients with emphysema in the National Emphysema Treatment Trial. Respir Care (2011) 1.40
Invasive Breast Cancer Version 1.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw (2016) 1.40
Precancerous stem cells have the potential for both benign and malignant differentiation. PLoS One (2007) 1.36
Psychological responses to cancer recurrence. Cancer (2005) 1.34
Phase II trial of bevacizumab in combination with weekly docetaxel in metastatic breast cancer patients. Clin Cancer Res (2006) 1.33
Natural killer cells produce T cell-recruiting chemokines in response to antibody-coated tumor cells. Cancer Res (2006) 1.32
Love, marriage, and divorce: newlyweds' stress hormones foreshadow relationship changes. J Consult Clin Psychol (2003) 1.30
Exercise accelerates wound healing among healthy older adults: a preliminary investigation. J Gerontol A Biol Sci Med Sci (2005) 1.30
Stress and wound healing. Neuroimmunomodulation (2007) 1.29
Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer. Carcinogenesis (2013) 1.28
Hostility and pain are related to inflammation in older adults. Brain Behav Immun (2006) 1.28
microRNA expression profiling identifies a four microRNA signature as a novel diagnostic and prognostic biomarker in triple negative breast cancers. Oncotarget (2014) 1.28
Depressive symptoms are associated with elevated serum proinflammatory cytokines among pregnant women. Brain Behav Immun (2009) 1.27
The small molecule curcumin analog FLLL32 induces apoptosis in melanoma cells via STAT3 inhibition and retains the cellular response to cytokines with anti-tumor activity. Mol Cancer (2010) 1.27
Loneliness predicts pain, depression, and fatigue: understanding the role of immune dysregulation. Psychoneuroendocrinology (2012) 1.26
Colocalization of the IL-12 receptor and FcgammaRIIIa to natural killer cell lipid rafts leads to activation of ERK and enhanced production of interferon-gamma. Blood (2008) 1.26
Poorer self-rated health is associated with elevated inflammatory markers among older adults. Psychoneuroendocrinology (2011) 1.25
PTSD diagnoses, subsyndromal symptoms, and comorbidities contribute to impairments for breast cancer survivors. J Trauma Stress (2008) 1.25
The EBV-encoded dUTPase activates NF-kappa B through the TLR2 and MyD88-dependent signaling pathway. J Immunol (2009) 1.25
IL-12 enhances the antitumor actions of trastuzumab via NK cell IFN-γ production. J Immunol (2011) 1.25
Piwil2 is expressed in various stages of breast cancers and has the potential to be used as a novel biomarker. Int J Clin Exp Pathol (2010) 1.24
IFN-alpha-induced signal transduction, gene expression, and antitumor activity of immune effector cells are negatively regulated by suppressor of cytokine signaling proteins. J Immunol (2007) 1.23